Issue Brief

Public Health and Consumer Groups Call for Participation in Antibiotic Use Meetings

On Nov. 2, 15 public health and consumer organizations sent a joint letter to the U.S. Food and Drug Administration (FDA) after the agency and the U.S. Department of Agriculture (USDA) announced they will hold public meetings across the country next year on ways to increase veterinary oversight of antibiotic use in food animal production.  In the letter, the organizations requested a seat at the table to ensure that discussions consider how the misuse and overuse of medically important antibiotics in livestock and poultry are significant contributing factors to antibiotic resistance in humans.

The meetings will engage large-animal veterinarians and farmers to ensure that any changes in antibiotic use policies will be achievable for industrial animal agriculture. However, at this point, there has been no indication that public health or consumer groups will be represented in these public discussions. Antibiotic use on the farm has significant impacts on human health, and it is critical that public health officials and consumer representatives have an equal voice on this issue.

November 2, 2012

Margaret A. Hamburg, M.D.
U.S. Food and Drug Administration
White Oak Building One
10903 New Hampshire Avenue, Room 2217
Silver Spring, MD 20993

Dear Commissioner Hamburg:

On behalf of the undersigned public health and consumer organizations, we wish to commend the U.S. Food and Drug Administration (FDA) for working with the U.S. Department of Agriculture (USDA) to plan a series of public stakeholder meetings across the country on ways to increase veterinary oversight of judicious antibiotic use in food animal production. We believe engaging large animal veterinarians and producers in such a dialogue is critical to achieving a smooth and successful transition to animal production methods that are less dependent on antibiotic use. However, we have not seen indication that these workshops will involve public health and consumer representation and urge the two agencies to ensure such participation.

As you know, misuse and overuse of medically important antibiotics in livestock and poultry is a significant contributing factor to antibiotic resistance in human pathogens. FDA has taken an important step by issuing Draft Guidance #213 to encourage drug makers to end the sale of antibiotics for production reasons (i.e., growth promotion and feed efficiency). Proposed changes to the Veterinary Feed Directive (VFD) — currently published in the form of draft pre-regulatory text — would partner with the guidance to achieve greater veterinary oversight of drugs that are today mainly used over-the-counter in farm animals. Expanding and modernizing the VFD will be a vital component to ensuring both the success of Guidance #213 in reducing on-farm antibiotic use and in protecting animal and public health.

Given that FDA’s plan to combat antibiotic resistance and antibiotic overuse in food animal production greatly impacts human health, we urge the agencies to include the public health community in each aspect of its design and implementation, including stakeholder dialogue on the VFD. We also urge the agency to finalize Guidance 213 and issue a formal proposed rule regarding VFD changes by the end of 2012. Public health must begin to take precedence over short-term animal production concerns immediately if we are to successfully protect the efficacy of our antibiotics in treating deadly human — and animal — infections.

Thank you again for your leadership in stemming the growing epidemic of antibiotic resistance.


Alliance for the Prudent Use of Antibiotics
American College of Preventive Medicine
American Public Health Association
Center for Food Safety
Center for Foodborne Illness Research & Prevention
Consumers Union
Food and Water Watch
Keep Antibiotics Working
Michigan Antibiotic Resistance Reduction Coalition
National Consumers League
Organic Consumers Association
The Johns Hopkins Center for a Livable Future
The Pew Charitable Trusts
Trust for America’s Health
Union of Concerned Scientists

Cc: The Honorable Thomas Vilsack, Secretary, U.S. Department of Agriculture, Michael R. Taylor, J.D., Deputy Commissioner for Foods, Linda Tollefson, DVM, MPH, Associate Commissioner, Office of Foods, Bernadette M. Dunham, DVM, PhD, Director, Center for Veterinary Medicine

Related Resources

Top Food Companies Moving Away From Overuse of Antibiotics on Industrial Farms

Consumers across the United States are demanding meat and poultry raised without antibiotics—and large producers, restaurants, and other institutions are listening. Following is a list of some leading companies offering responsibly produced food.


FDA Reports that 25 of 26 Antibiotic Makers Will Comply with New Policies

On March 26, the U.S. Food and Drug Administration announced that 25 out of 26 drug companies that sell antibiotics for growth promotion “confirmed in writing their intent to engage with FDA as defined in Guidance #213.” FDA introduced this policy in final form Dec. 11, 2013, to curb antibiotic overuse and increase veterinary oversight on industrial farms. More

200,000+ Americans to FDA: Require Real Veterinary Oversight of Antibiotics on Industrial Farms

Three months ago, the U.S. Food and Drug Administration took an important step to protect people from superbugs. For the first time, it issued a set of proposed policies that would require food producers and feed mills to obtain a veterinarian’s order before adding antibiotics to animal feed or water. More

New FDA Policies on Antibiotics Use in Food Animal Production

Surveys of the animal production industry by the U.S. Department of Agriculture demonstrate that many farms and ranches administer antibiotics to healthy animals at low doses to offset overcrowding and poor sanitation and to accelerate livestock growth—practices that the medical and public health communities document as a significant factor in human antibiotic resistance. In 2013, FDA took steps to address these concerns.



MRSA, Football, and Industrial Farms

MRSA, or methicillin-resistant Staphylococcus aureus, is a type of bacteria that can infect a person’s skin, bones, lungs, heart, brain, and blood. Unlike common staph, MRSA does not respond to traditional antibiotics such as penicillin, making it more difficult and costlier to treat, and more lethal.